--- title: "PF-07321332 Supply Agreement for Pandemic Purposes" ocid: "ocds-h6vhtk-02f7bb" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02f7bb" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-02f7bb.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-02f7bb.json" source: "Find A Tender Service" current_stage: "Award" buyer: "DEPARTMENT OF HEALTH AND SOCIAL CARE" published: "2021-11-17" --- # PF-07321332 Supply Agreement for Pandemic Purposes Buyer: DEPARTMENT OF HEALTH AND SOCIAL CARE Current stage: Award OCID: ocds-h6vhtk-02f7bb [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02f7bb) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-02f7bb.json) ## Summary The Department of Health and Social Care in London has concluded a tender for the "PF-07321332 Supply Agreement for Pandemic Purposes," which falls under the pharmaceutical products category, specifically focusing on antiviral drugs. The procurement was carried out via a limited method without prior publication due to extreme urgency related to the COVID-19 pandemic. The contract involved the supply of 250,000 units of PF-07321332/ritonavir. Although the award has been made active as of 18th October 2021, it's worth noting that this tender has been completed, with the award criteria primarily focused on price. This tender represents a significant opportunity for businesses, especially those operating in the pharmaceutical and healthcare sectors, to engage in critical supply chains during the ongoing public health crisis. Companies with capabilities in the production and supply of antiviral medications, particularly those experienced in large-volume pharmaceutical manufacturing, would be well-suited to compete in future procurement processes related to antiviral products. Additionally, businesses that can quickly innovate and provide novel solutions in response to health emergencies may find a growing market for their offerings as the Department of Health and Social Care seeks to expand its antiviral portfolio. ## Notice Vaccines have been shown to be highly effective in the fight against COVID-19, to date. However, there is a cohort of individuals who either cannot take the vaccine or for whom it is ineffective. There is therefore an urgent need to find an effective alternative. So far there are no primary care antiviral drugs that can be easily dispensed specifically to treat SARS-CoV-2 and prevent its transmission in the community.This agreement is for the procurement of 250,000 units of PF-07321332/ritonavir . It is one of the first oral and direct-acting antiviral drugs globally and is part of the UK's multi-layered approach to COVID-19. ### Procurement Information Regulation 32(2)(c)The procurement was initiated on the basis that Regulation 32(2)(c) was applicable. In April 2021, the Antivirals Task Force (ATF) was established as it was recognised there was an urgent to find alternative novel anti-viral treatments. As far as is strictly necessary: The use of antivirals was identified as strictly necessary for the cohort of individuals for whom a vaccine is not an option. There are genuine reasons for extreme urgency: The procurement of antivirals aims to protect vulnerable cohorts of the population. This risk of public health presents a genuine emergency.The events that have led to the need for extreme urgency were unforeseeable: There are many aspects of the COVID-19 pandemic, which have been entirely unforeseeable. DHSC is acting on the newest information it has available to tailor its COVID-19 response accordingly. The situation is not attributable to the contracting authority: The situation of extreme urgency is not attributable to DHSC.It is impossible to comply with the usual timescales in the PCR: When the need for antivirals was urgently identified in April 2021, DHSC conducted a comprehensive market review. The result of this exercise was that it became clear that a procurement exercise could not be run due to the absence of competition. If the ATF were to run a procurement process now, it would worsen DHSC's position.Regulation 32 (2) (b) (ii)In the course of this procurement, it has become clear to DHSC that Regulation 32(2)(b)(ii) is applicable. The antivirals market is inverted, with an imbalance between demand and supply and limited worldwide supply capacity. This means there will be a finite supply of antivirals available in 2021/22: to date only two antivirals have received or have the potential to gain MHRA approval for Autumn/Winter 2021.Looking forward, DHSC is expected to publish a Prior Information Notice (PIN) in November in respect of its likely further portfolio requirements with a view to running future open procurement exercises where possible. Please see Contracts Finder Notice for full justification. ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/028748-2021 | | Notice type | Award Notice | | Procurement type | Standard | | Procurement category | Goods | | Procurement method | Limited | | Procurement method details | Award procedure without prior publication of a call for competition | | Tender suitability | Not specified | | Awardee scale | Large | | All stages | Award | ## Dates | Field | Value | | --- | --- | | Publication date | 17 Nov 2021 | | Submission deadline | Not specified | | Future notice date | Not specified | | Award date | 17 Oct 2021 | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | Not specified | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Complete | | Lots status | Cancelled | | Awards status | Active | | Contracts status | Active | ## Buyer | Field | Value | | --- | --- | | Main buyer | DEPARTMENT OF HEALTH AND SOCIAL CARE | | Locality | LONDON | | Post town | South West London | | Postcode | SW1H 0EU | | Country | England | | ITL 1 | TLI London | | ITL 2 | TLI3 Inner London - West | | ITL 3 | TLI35 Westminster and City of London | | Local authority | Westminster | | Electoral ward | St James's | | Westminster constituency | Cities of London and Westminster | | Delivery location | Not specified | ## Supplier | Field | Value | | --- | --- | | Number of suppliers | 1 | | Supplier names | PFIZER | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33600000 - Pharmaceutical products ## Release History - 17 Nov 2021 at 18:41 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/028748-2021 ## Notice URLs - https://www.gov.uk/courts-tribunals - https://www.gov.uk/government/organisations/department-of-health-and-social-care ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02f7bb. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-02f7bb.json.